Applied Therapeutics Inc
NASDAQ:APLT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Applied Therapeutics Inc
NASDAQ:APLT
|
US |
|
G
|
Gielda Praw Majatkowych Vindexus SA
WSE:VIN
|
PL |
|
Metabolic Explorer SA
PAR:METEX
|
FR |
|
F
|
Fujitsu General Ltd
SWB:29F
|
JP |
|
Altimmune Inc
NASDAQ:ALT
|
US |
|
Sogeclair SA
PAR:SOG
|
FR |
|
L
|
Linius Technologies Ltd
OTC:LNNTF
|
AU |
|
C
|
Cardiol Therapeutics Inc
NASDAQ:CRDL
|
CA |
|
R
|
Rocca SA
WSE:RCA
|
PL |
|
O
|
Open Text Corp
NASDAQ:OTEX
|
CA |
|
Precise Biometrics AB
STO:PREC
|
SE |
|
Redde Northgate PLC
LSE:REDD
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is APLT's stock price target?
Not Available
APLT doesn't have any price targets made by Wall Street professionals.
What is Applied Therapeutics Inc's Revenue forecast?
Projected CAGR
248%
The
compound annual growth rate
of
Applied Therapeutics Inc's revenue for the next 4 years is
248%.